Sheila Villacastin
Adult Health · Citrus Springs, FLNPI 1164629614
Payments from drug & device makers
Across 316 payments — averaging $24.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$1K
- Novo Nordisk$1K
- GSK$609
- Biohaven Pharmaceuticals, Inc.$514
- Johnson & Johnson$434
- plus $2K from 27 others
What the payments were for
- Food & beverage$7,787100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 79 | $1,631 |
| AstraZeneca | 25 | $1,160 |
| Novo Nordisk | 48 | $1,114 |
| GSK | 32 | $609 |
| Biohaven Pharmaceuticals, Inc. | 12 | $514 |
| Johnson & Johnson | 7 | $434 |
| Otsuka America Pharmaceutical, Inc. | 14 | $360 |
| Pfizer | 18 | $313 |
| Lilly USA, LLC | 16 | $251 |
| Amgen | 4 | $178 |
| Sanofi-aventis U.S. LLC | 8 | $153 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $144 |
| Bayer | 7 | $144 |
| Esperion Therapeutics, Inc. | 4 | $125 |
| Nestle Healthcare Nutrition Inc. | 5 | $90 |
| Boehringer Ingelheim | 2 | $76 |
| Amarin Pharma, Inc. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $56 |
| Novartis | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Idorsia Pharmaceuticals US Inc | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 1 | $35 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| UCB, Inc. | 1 | $28 |
| Sun Pharmaceutical Industries Inc. | 1 | $19 |
| Evoke Pharma, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Radius Health, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $15 |
| Corium, LLC | 1 | $15 |
| Exact Sciences | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,789 in reported general payments places this provider in the 95th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 74 | $130,414 |
| MounjaroTirzepatide | 87 | $115,735 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 71 | $73,277 |
| EliquisApixaban | 48 | $63,371 |
| FarxigaDapagliflozin Propanediol | 42 | $43,811 |
| VraylarCariprazine Hcl | 28 | $41,058 |
| JanuviaSitagliptin Phosphate | 24 | $38,873 |
| JardianceEmpagliflozin | 21 | $29,422 |
| TrulicityDulaglutide | 16 | $24,218 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 20 | $19,381 |
| MyrbetriqMirabegron | 20 | $14,005 |
| Repatha SureclickEvolocumab | 12 | $13,916 |
| Nurtec OdtRimegepant Sulfate | 12 | $12,057 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $11,340 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $9,987 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $251 | $139,953103 claims |
| Novo NordiskOzempic | $1,114 | $130,41474 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $609 | $103,998104 claims |
| PfizerEliquis, Nurtec Odt | $313 | $75,42860 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $1,160 | $63,56578 claims |
| AbbVieVraylar, Synthroid | $1,631 | $43,35148 claims |
| Boehringer IngelheimJardiance | $76 | $29,42221 claims |
| Astellas Pharma US IncMyrbetriq | $15 | $14,00520 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $40 | $5,22811 claims |
| Esperion Therapeutics, Inc.Nexlizet | $125 | $4,51711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,237 adult health providers in Florida.
Other adult health in Citrus Springs
- Alexander VillacastinCitrus Springs$15K
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Alejandro Dela CruzOrlando$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.